ScripAhead of World AIDS Day on 1 December, China's Center for Disease Control and Prevention said on 30 November that the country’s mother-to-newborn HIV infections and through sexual transmission are at
ScripEying the benefits of low-cost manufacturing and the potential to treat mutations, Chinese companies are tapping into peptide fusion inhibitors for the prevention and treatment of COVID-19. The drugs'
ScripChinese biotechs are encountering investors who appear to have been balking at acquiring their new shares since early September, with one private equity funding scrapped, a re-financing deal reduced a
ScripShanghai-listed Frontier Biotechnologies Inc is betting CNY353m ($52m) to kickstart a pivotal global Phase II/III clinical trial to investigate an antiviral candidate in hospitalized patients with m